(+)-4-epi-alpha-bisabolol,
bisabolol,
bisabolol, (+)-isomer,
bisabolol, (-)-isomer,
levomenol,
LEVOMENOL,
(-)-alpha-Bisabolol,
alpha-Bisabolol,
23089-26-1,
Bisabolol,
Kamillosan,
UNII-24WE03BX2T,
alpha-(-)-Bisabolol,
CHEBI:125,
24WE03BX2T,
RGZSQWQPBWRIAQ-CABCVRRESA-N,
(2S)-6-methyl-2-[(1S)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol,
Levomenolum,
Kamilosan,
(-)-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol,
1-alpha-Bisabolol,
Levomenol [INN],
alpha-Bisabolol, L-,
alpha-Bisabolol (-)-form,
515-69-5,
Levomenolum [INN-Latin],
Bisbalol,
CCRIS 9081,
3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, [S-(R*,R*)]-,
EINECS 245-423-3,
l-.alpha.-Bisabolol,
(-)-|A-Bisabolol,
.alpha.-Bisabolol, L-,
AC1L9CMZ,
.alpha.-(-)-Bisabolol,
(-)--BISABOLOL,
ALPHA-(-)BISABOLOL,
DSSTox_CID_22094,
DSSTox_RID_79924,
DSSTox_GSID_42094,
SCHEMBL24989,
.alpha.-Bisabolol (-)-form,
((-))-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol,
CHEMBL1096927,
DTXSID4042094,
ZINC1849759,
[S-(R*,R*)]-.alpha.-Bisabolol,
Tox21_301375,
5-Hepten-2-ol, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-, (-)-,
BDBM50382730,
MFCD03412455,
DB13153,
LMPR0103060001,
(-)-alpha-Bisabolol, >=93% (GC),
NCGC00255987-01,
(-)-alpha-Bisabolol, analytical standard,
CAS-23089-26-1,
Alpha-Bisabolol 1000 microg/mL in Isopropanol,
C09621,
J-014978,
UNII-36HQN158VC component RGZSQWQPBWRIAQ-CABCVRRESA-N,
(-)-alpha-Bisabolol, primary pharmaceutical reference standard,
Levomenol, United States Pharmacopeia (USP) Reference Standard,
6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol, (-)-,
3-Cyclohexene-1-methanol, a,4-dimethyl-a-(4-methyl-3-pentenyl)-,(aS,1S)-,
[S-(R*,R*)]-.alpha.,4-Dimethyl-.alpha.-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol,
3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (-)-,
3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (.alpha.S,1S)-,
3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (alphaS,1S)-,
3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (S-(theta,theta))-,
a-Bisabolol,
.alpha.-Bisabolol,
-ALPHA-BISABOLOL,
bisabolol, (+)-isomer,
bisabolol, (-)-isomer,
UNII-36HQN158VC,
(+)-4-epi-alpha-bisabolol,
C15H26O,
EINECS 208-205-9,
EINECS 246-973-7,
C15-H26-O,
CID442343,
C004497,
6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol,
3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, (R,R)-,
alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)-3-cyclohexene-1-methanol,
(alpha R,1R)-rel-alpha,4-Dimethyl-alpha-(4-methyl-3-penten-1-yl)-3-cyclohexene-1-methanol,
(R*, R*)- a, 4- dimethyl- a- (4- methyl- 3- pentenyl)cyclohex- 3- ene- 1- methanol,
(R*,R*)-alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol,
3-ciclohexeno-1-metanol, ?,4-dimetil-?-(4-metil-3-penten-1-il)-, (?s,1s)-,
3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (R*,R*)-,
3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, [S-(R,R)]-,
3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (S-(R*,R*))-,
(R*,R*) - a,4 - dimethyl - a - (4 - methyl - 3 - pentenyl)cyclohex - 3 - ene - 1 - methanol,
3-ciclohexeno-1-metanol, Alfa,4-Dimetil-Alfa-(4-metil-3-penten-1-il)-, (Alfa R, 1R)-rel-,
3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (.alpha.R,1R)-rel-,